The lower presence of both CD4-positive and CD8-positive T cells in the growing left ovarian tumor than in the uterine tumor suggests that immune tolerance after LP therapy may have occurred, potentially leading to resistance to LP therapy in the left ovarian tumor. The gene discussed is CD4; the disease is ovarian neoplasm.